showed a trendP =0.10
Subjects on HMC with body mass index (BMI) <25 kg/m 2 showed a trend toward decreased pain scores ( P =0.10), while pain increased in those administered placebo.
Subjects on HMC with body mass index (BMI) <25 kg/m 2 showed a trend toward decreased pain scores ( P =0.10), while pain increased in those administered placebo.
TNF-α increased by 25% from baseline to week 4 in the placebo group but only by 15% when on HMC ( P =0.07), suggesting a positive trend.